Skip to main content
Caplight Logo









BioFishency

BioFishency

Private
IsraelFrontier & Industrial Techhttps://biofishency.com

Last Round

Series A

Mar 27, 2019

Total Funding Raised

$3.5M

Company Overview

BioFishency operates in Frontier & Industrial Tech and is based in Israel. Its latest recorded funding round was a Series A round in March 2019.

BioFishency is an aquaculture technology company that develops, manufactures, and markets water treatment solutions for land-based aquaculture.

Sector

Frontier & Industrial Tech

Verticals

Water Treatment, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts, Hardware + Subscription

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

BioFishency Comparables

Compare BioFishency with similar companies based on industry and business-model similarity.

BioFishency comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Clewer Aquaculture Oy
83%
HESY Aquaculture B.V.
82%
Aquacultr Group
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

BioFishency Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 27, 2019
SeedMar 1, 2013
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

BioFishency Investors

Notable investors and investment history

BioFishency investors
InvestorRounds
Aqua-SparkSeries A
The Trendlines GroupSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 21, 2025

    Monthly visitors grew 3057% MoM, from 7 to 221.

  • Mar 27, 2019

    $2.4M round led by Aqua-Spark

Book a demo to see all signals

For institutional investors. Book with your work email.

BioFishency Filings

Explore SEC and related filing metadata, where available.

BioFishency filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about BioFishency's valuation, stock price, and market status.

Is BioFishency a public or private company?

BioFishency is a private company.

What is the current stock price of BioFishency?

BioFishency is a private company, so its shares have no public market price. Caplight tracks BioFishency's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is BioFishency worth (valuation)?

Valuation information for BioFishency is not publicly available.

Can I buy BioFishency stock?

BioFishency shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was BioFishency's last funding round?

BioFishency's most recent funding round was Series A on March 27, 2019.

Who are the main investors in BioFishency?

Key investors in BioFishency include Aqua-Spark, The Trendlines Group.

Will BioFishency IPO soon?

No public IPO plans have been announced for BioFishency.

How can I track BioFishency secondary market activity?

Caplight tracks bids, offers, and trades in BioFishency's shares on secondary markets.

Firmographic Details

HeadquartersIsrael
Employee Range2
Year Founded2013
Last FundingMar 27, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?